Yuxian Bai
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Hepatology top 0.5%
- Surgery top 2%
- Co-authors
- Shukui QinJianming XuYing ChengTianshu LiuYanjing LiJianping XiongZhenggang RenHongming Pan
- Topics
- Gastric Cancer Management and Outcomes (63 papers)Colorectal Cancer Treatments and Studies (59 papers)Cancer Immunotherapy and Biomarkers (38 papers)
- Cited by
- HepatologyOncologyGastroenterology
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yuxian Bai
177 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 3.2k
- Pulmonary and Respiratory Medicine 2.3k
- Molecular Biology 1.5k
- Hepatology 1.4k
- Surgery 1.2k
Countries citing papers authored by Yuxian Bai
This map shows the geographic impact of Yuxian Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxian Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxian Bai more than expected).
Fields of papers citing papers by Yuxian Bai
This network shows the impact of papers produced by Yuxian Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxian Bai. The network helps show where Yuxian Bai may publish in the future.
Co-authorship network of co-authors of Yuxian Bai
This figure shows the co-authorship network connecting the top 25 collaborators of Yuxian Bai. A scholar is included among the top collaborators of Yuxian Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxian Bai. Yuxian Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 16 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 0 | |
| 10 | 75 | |
| 11 | Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trialbreakdown → | 127 |
| 12 | 7 | |
| 13 | The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancerbreakdown → | 449 |
| 14 | 70 | |
| 15 | 13 | |
| 16 | 38 | |
| 17 | 23 | |
| 18 | 23 | |
| 19 | 63 | |
| 20 | 22. Expression and clinical significance of TF and Her-2 in gastric carcinoma | 1 |
About Yuxian Bai
Yuxian Bai is a scholar working on Oncology, Gastroenterology and Hepatology, having authored 187 papers that have together received 6.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (63 papers), Colorectal Cancer Treatments and Studies (59 papers) and Cancer Immunotherapy and Biomarkers (38 papers). The work is most often cited by research in Hepatology (1.4k citations), Oncology (3.2k citations) and Gastroenterology (426 citations). Yuxian Bai has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shukui Qin, Jianming Xu, Ying Cheng, Tianshu Liu, Yanjing Li, Jianping Xiong, Zhenggang Ren, Hongming Pan, Rui‐Hua Xu and Shukui Qin. Their work appears in journals such as Nature, The Lancet and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.